May 27, 2016
Galderma Laboratories recently announced that a new pump dispenser design for Mirvaso topical gel, 0.33% is available to treat persistent erythema associated with rosacea in adults.
Mirvaso (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist. The Mirvaso Gel Pump is available by prescription in U.S. pharmacies, according to a press release. The pump’s delivery system dispenses a consistent dose at each use.